Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients

Area of Science:

• Pharmacology
• Nephrology
• Immunology

Background:

• Pediatric kidney transplant graft survival has improved due to new immunosuppressants and enhanced care.
• Long-term graft survival, especially from deceased donors, still requires optimization in pediatric patients.
• Maintenance immunosuppressive therapies exhibit narrow therapeutic indices and significant variability.

Purpose of the Study:

• To review the impact of pharmacokinetic variability on renal transplantation outcomes.
• To explore factors contributing to immunosuppressant variability in pediatric kidney transplant recipients.
• To outline pharmacodynamics, adverse effects, and biomarkers of immunosuppressants.

Main Methods:

• Literature review examining pharmacokinetic variability in renal transplantation.
• Analysis of factors including age, genetics, drug interactions, and formulation.
• Outline of immunosuppressant pharmacodynamics, adverse effects, and biomarkers.

Main Results:

• Pharmacokinetic variability is influenced by age, genetic polymorphisms, drug-drug/disease interactions, renal insufficiency, administration route, and drug formulation.
• Pharmacodynamic aspects include mechanism of action, adverse effects, and biomarker utility.
• Understanding variability is key to balancing efficacy and toxicity.

Conclusions:

• A quantitative understanding of immunosuppressant pharmacokinetics and pharmacodynamics is essential.
• Improved understanding will aid clinicians in optimizing treatment regimens.
• This optimization aims to enhance therapeutic efficacy while minimizing drug-related toxicity in pediatric kidney transplant patients.